• 제목/요약/키워드: Consecutive tests

검색결과 146건 처리시간 0.024초

Molecular Investigation of Two Consecutive Nosocomial Clusters of Candida tropicalis Candiduria Using Pulsed-Field Gel Electrophoresis

  • Park, Joon;Shin, Jong-Hee;Song, Jeong-Won;Park, Mi-Ra;Kee, Seung-Jung;Jang, Sook-Jin;Park, Young-Kyu;Suh, Soon-Pal;Ryang, Dong-Wook
    • Journal of Microbiology
    • /
    • 제42권2호
    • /
    • pp.80-86
    • /
    • 2004
  • Pulsed-field gel electrophoresis (PFGE) typing was applied to the epidemiological investigation of 21 Candida tropicalis isolates collected from urine specimens of 11 patients and one healthcare worker, in an intensive care unit (ICU) over a 4-month period. Seventeen epidemiologically unrelated strains from 14 patients were also tested to determine the discriminatory power of PFGE. PFGE typing consisted of electrophoretic karyotyping (EK) and restriction endonuclease analysis of genomic DNA (REAG), using two restriction enzymes (BssHII and SfiI). The EK pattern was the same in all 38 isolates, while REAG using SfiI separated the isolates into nine types. However, 16 different PFGE types were iden-tified by REAG with BssHII, and the same results were obtained when the results of both REAG tests were combined. In serial urinary isolates from 10 patients, all strains from each patient had the same PFGE pattern. While the epidemiologically unrelated strains from 14 patients consisted of 13 different PFGE types, the 20 isolates from the 11 ICU patients fell into only two PFGE types (types Cl and C2), and these apparently originated from the two different outbreaks. All strains of type Cl (n = 12) were isolated from six patients, between November 1999 and January 2000, and all of the type C2 strains (n=8) were isolated from five patients, during January and February 2000. This study shows two con-secutive clusters of C. tropicalis candiduria in an ICU, defined by PFGE typing, and also demonstrates that a PFGE typing method using BssHII is perhaps the most useful method for investigating C. tropi-calis candiduria.

지연성 근육통(delayed onset muscle soreness)에 대한 경피선경자극(transcutaneous electrical nerve stimulation)의 효과 (Effects of Transcutaneous Electrical Nerve Stimulation on Delayed Onset Muscle Soreness)

  • 남기석;이윤주;김종만
    • 한국전문물리치료학회지
    • /
    • 제4권3호
    • /
    • pp.70-83
    • /
    • 1997
  • The purpose of this study was to determine the effects of transcutaneous electrical nerve stimulation(TENS) on delayed onset muscle soreness(DOMS). Twenty males performed eccentric exercise of the elbow flexor. Subjects were randomly assigned to one of three groups: 1) a group ($n_1$=7) that received low frequency TENS (7 Hz), 2) a group ($n_2$=7) that received high frequency TENS (500 Hz), 3) a control group ($n_3$=6) that received no treatment. DOMS was induced in a standardised fashion in the non-dominant elbow flexor of all subjects by repeated eccentric exercise. Treatments were applied immediately following exercise and again at 24 hours and at 48 hours after. Subjects attended on three consecutive days for treatment and measurement of elbow flexion, extension and resting angle(universal goniometer), and pain(Visual Analogue Scale; VAS) on a daily basis. Measurements were taken after treatment. Analysis of results using repeated measures analysis of variance(ANOVA) and post hoc tests were as follows: 1) there were between groups differences in pain value at 48 hours after (p<0.05), 2) one-way ANOVA with repeated measurement for pain, resting angle, flexion angle and extension angle revealed significant differences within low frequency TENS group, 3) one-way ANOVA with repeated measurement for flexion angle revealed significant difference within high frequency TENS group.

  • PDF

바나듐 및 크롬을 포함하는 다 성분 Boride 코팅의 생성 및 특성 평가 (Formation of Multi-Component Boride Coatings Containing V and/or Cr and Evaluation of Their Properties)

  • 이의열;윤상혁;김종하
    • 한국표면공학회지
    • /
    • 제49권2호
    • /
    • pp.211-217
    • /
    • 2016
  • Boride coating applied on steam turbine parts of power plants has provided good particle erosion resistance under temperature of $550^{\circ}C$, but it isn't able to protect the parts effectively any more in ultra super critical (USC) steam turbine which is being operated up to temperature of $650^{\circ}C$. To ensure stable durability for USC steam turbine parts, an alternative coating replacing boride coating should be developed. In this study, multi-component boride coatings containing elements such as chromium (Cr) and vanadium (V) were formed on base metal (B50A365B) using thermochemical treatment method called by pack cementation. The thermochemical treatments involve consecutive diffusion of boron(B) and Cr or/and V using pack powders containing diffusion element sources, activators and diluents. The top layer of Cr-boride coating is primarily consisted of $Cr_2B_3$ and $Cr_5B_3$, while that of V-boride coating is mostly consisted of $VB_2$ and $V_2B_3$. The (Cr,V)-boride coating is consisted of $Cr_2B_3$, $Cr_5B_3$ and $V_2B_3$ mostly. The top surfaces of 3 multi-component boride coatings show hardness of $3200-3400H_v$, which is much higher than that of boride, about $1600-2000H_v$. In 5 wt.% NaCl solution immersion tests, the multi-component boride coatings show much better corrosion resistance than boride coating.

현장실험을 통한 포스트텐션드 프리스트레스트 콘크리트 포장의 긴장 시 거동분석 (Field Measurement and Analysis of Post-Tensioned Prestressed Concrete Pavement Behavior under Tensioning)

  • 박희범;김성민;김동호
    • 한국도로학회논문집
    • /
    • 제11권1호
    • /
    • pp.247-256
    • /
    • 2009
  • 본 연구는 포스트텐션드 프리스트레스트 콘크리트 포장(PTCP: Post-Tensioned prestressed Concrete Pavement) 공법의 국내 적용을 위해 수행한 시험시공시에 현장실험을 통해 PTCP의 긴장시 구조적 거동을 분석하기 위하여 수행되었다. 실험을 위해 온도측정센서 및 변위측정게이지를 슬래브에 장착하여 환경하중 및 긴장력 도입에 따른 슬래브의 변위변화를 측정하였다. 총 세 차례에 걸쳐 긴장력을 도입하였으며 긴장작업의 적절성을 온도와 변위의 상관관계 횡방향 균열거동, 일일 종방향 변위변화량 등을 분석하여 판단하였다. 실험결과 타설초기 1차 긴장시에는 슬래브와 하부층과의 마찰 및 콘크리트의 소성성질 등의 요인에 의해 슬래브의 양끝단 부분에서만 큰 변위가 발생하였으나 이후 어느 정도의 시간이 경과한 후 가해진 긴장에서는 슬래브 전체에 뚜렷한 변위가 발생되나 여전히 마찰저항의 영향을 받는 것으로 분석되었다. 또한 긴장이 제대로 가해지면 균열이 존재하더라도 비활성화되어 슬래브가 일체의 거동을 나타내었다.

  • PDF

Comparison of Surgical Outcomes of Laparoscopic Adrenalectomy Between Patients With Nonfunctioning Adrenal Adenomas and Subclinical Cushing Syndrome: A Single-Center Experience

  • Kang, Minyong;Baek, Minki;Lee, Jonghoon;Jeong, Byong Chang
    • 대한비뇨기종양학회지
    • /
    • 제15권3호
    • /
    • pp.137-142
    • /
    • 2017
  • Purpose: To examine and compare the perioperative outcomes of laparoscopic adrenalectomy (LA) and to determine its efficacy in patients with nonfunctioning adrenal adenomas (NFA) and subclinical Cushing syndrome (SCS). Materials and Methods: We retrospectively analyzed the clinical data obtained from 79 consecutive patients who underwent LA for the treatment of either NFA (n=35) or SCS (n=44) between 2011 and 2016. All patients had undergone computed tomography, as well as endocrinological tests to confirm the diagnosis prior to the adrenalectomy. The primary endpoint was improved metabolic parameters relating to diabetes, hypertension, dyslipidemia, and obesity. Results: Patients with SCS compared to those with NFA showed a higher occurrence of diabetes (29.5% vs. 11.4%), hypertension (59.1% vs. 34.3%), and dyslipidemia (43.2% vs. 14.3%). Patients with SCS showed a smaller median tumor size compared to those with NFA (2.5 cm vs. 5 cm). No significant perioperative complications ${\geq}$ Clavien-Dindo classification grade III were observed in any patient (SCS or NFA group). In terms of their metabolic profile, patients with SCS showed a significant postoperative improvement in hypertension (50.0%), diabetes (53.9%), dyslipidemia (31.6%), and obesity (29.2%). However, patients with NFA showed a postoperative improvement only in dyslipidemia (40.0%) and obesity (4.8%). Conclusions: Owing to absence of significant perioperative complications and the marked postoperative improvement in metabolic impairment, LA is a useful treatment strategy in patients diagnosed with SCS. In contrast, LA was not observed to show beneficial effects in correcting/improving the metabolic profile in patients presenting with NFA.

A bioassay system for pharmacological standardization of Withania somnifera derived herbal remedies

  • Dey, Amitabha;Chatterjee, Shyam Sunder;Kumar, Vikas
    • 셀메드
    • /
    • 제9권1호
    • /
    • pp.1.1-1.13
    • /
    • 2019
  • Background: Contents of bioactive substances extractable from different parts of terrestrial plants vary enormously. Aim: To ascertain that parts of Withania somnifera other than its roots can also be used for prevention and cure of unavoidable stress triggered central hypersensitivity to pain. Material and Methods: Groups of male or female mice treated either with Withania somnifera extracts or with metformin, aspirin, imipramine, diazepam and niacin for 11 consecutive days were subjected to "foot-shock stress-induced hyperthermia" and "hot plate" tests on the 1st, 5th, 7th, and 10th days of the experiments. On the 11th day, they were subjected to tail suspension test and on 12th day pentobarbital hypnosis test. Results: Except for diazepam and imipramine, protective effects of all other tested drugs as well as of the Withania somnifera extracts against stress-induced central hypersensitivity to pain were accompanied by their preventive effects against foot-shock stress-induced body weight losses. All observed stress response suppressing effects of all test agents increased with increasing numbers of treatment days. However, mean duration of pentobarbital-induced sleep was shorter in the extracts treated groups and longer in the diazepam treated ones only. Conclusions: Reported observations reveal that pharmacological activity profile of Withania somnifera extracts in male and female mice are almost identical, and are not like those of several drugs currently often prescribed for the treatment of diabetes-associated comorbidities. Withanolides are not the only extractable bioactive constituents of Withania somnifera. The described bioassay system is well suited for pharmacological standardization of diverse types of Withania somnifera extracts.

Iodine Quantification on Spectral Detector-Based Dual-Energy CT Enterography: Correlation with Crohn's Disease Activity Index and External Validation

  • Kim, Yeon Soo;Kim, Se Hyung;Ryu, Hwa Sung;Han, Joon Koo
    • Korean Journal of Radiology
    • /
    • 제19권6호
    • /
    • pp.1077-1088
    • /
    • 2018
  • Objective: To correlate CT parameters on detector-based dual-energy CT enterography (DECTE) with Crohn's disease activity index (CDAI) and externally validate quantitative CT parameters. Materials and Methods: Thirty-nine patients with CD were retrospectively enrolled. Two radiologists reviewed DECTE images by consensus for qualitative and quantitative CT features. CT attenuation and iodine concentration for the diseased bowel were also measured. Univariate statistical tests were used to evaluate whether there was a significant difference in CTE features between remission and active groups, on the basis of the CDAI score. Pearson's correlation test and multiple linear regression analyses were used to assess the correlation between quantitative CT parameters and CDAI. For external validation, an additional 33 consecutive patients were recruited. The correlation and concordance rate were calculated between real and estimated CDAI. Results: There were significant differences between remission and active groups in the bowel enhancement pattern, subjective degree of enhancement, mesenteric fat infiltration, comb sign, and obstruction (p < 0.05). Significant correlations were found between CDAI and quantitative CT parameters, including number of lesions (correlation coefficient, r = 0.573), bowel wall thickness (r = 0.477), iodine concentration (r = 0.744), and relative degree of enhancement (r = 0.541; p < 0.05). Iodine concentration remained the sole independent variable associated with CDAI in multivariate analysis (p = 0.001). The linear regression equation for CDAI (y) and iodine concentration (x) was y = 53.549x + 55.111. For validation patients, a significant correlation (r = 0.925; p < 0.001) and high concordance rate (87.9%, 29/33) were observed between real and estimated CDAIs. Conclusion: Iodine concentration, measured on detector-based DECTE, represents a convenient and reproducible biomarker to monitor disease activity in CD.

Scopolamine 유발 기억력 손상 마우스 모델에서 분심기음의 항산화 및 기억력 감퇴 억제 효과 (Anti-amnesic and Antioxidant Effect of Bunsimgieum (Fenxinqiyin) on Scopolamine-Induced Memory Impairment in Mice)

  • 한다영;유옥철;김상호;정대규
    • 동의신경정신과학회지
    • /
    • 제30권3호
    • /
    • pp.221-235
    • /
    • 2019
  • Objectives: The purpose of this study was to confirm the anti-amnesic effects of Bunsimgieum (BSGE) through its favorable acetylcholine (ACh) and, acetylcholinesterase (AChE) activity, choline acetyltransferase (ChAT) mRNA expressions, and antioxidant effect on scopolamine (Sco)-induced memory impairment in C57BL/6 mice. Methods: Six groups, a total of 20 intact or 100 Sco-induced mice were used in this study, based on their body weight. Half of each group underwent passive avoidance tests and the measurement of hippocampus AChE activity, ACh content, and ChAT mRNA expression, The remaining half of each group underwent a Morris water-maze test and antioxidant defense system measurement as well. Results: Significant reductions in the step-through latency times from the passive avoidance test and reductions in the escape latency times from the Morris water-maze test were observed with increases of hippocampal AChE activities and, reductions in ACh contents and ChAT mRNA expression in hippocampus, as a result of Sco intraperitoneal treatment, in this study. Additionally, the increases in cerebral cortical MDA levels and, reductions in GSH contents, SOD activities, and CAT activities were demonstrated in the Sco control mice compared with the intact vehicle control mice, respectively. However, 28 days of consecutive oral pre-treatment of BSGE hot water extracts of 400, 200, and 100 mg/kg, respectively, markedly and dose-dependently inhibited Sco treatment-related amnesia. Conclusions: The results demonstrate that the oral administration of BSGE hot water extracts reduces Sco-induced memory impairment, through preserving ACh, related to ChAT mRNA expressions, causes AChE inhibition, and enhances the cerebral antioxidant defense system.

Genotoxicity and subchronic toxicological study of a novel ginsenoside derivative 25-OCH3-PPD in beagle dogs

  • Li, Wei;Zhang, Xiangrong;Ding, Meng;Xin, Yanfei;Xuan, Yaoxian;Zhao, Yuqing
    • Journal of Ginseng Research
    • /
    • 제43권4호
    • /
    • pp.562-571
    • /
    • 2019
  • Background: Ginsenosides have been widely used clinically for many years and were regarded as very safe. However, a few researches on the toxicities of these kinds of agents showed that some ginsenosides may have side-effect on the rats or dogs. So it is extremely necessary to further clarify the potential toxicity of ginsenosides. This study was carried out to investigate long-term toxicity and genotoxicity of 25-methoxydammarane-3, 12, 20-triol ($25-OCH_3-PPD$), a new derivative of ginsenoside, in beagle dogs. Methods: Twenty-four beagle dogs were divided randomly into four treatment groups and repeatedly orally administered with $25-OCH_3-PPD$ capsule at 60, 120, and 240 mg/kg/day for 91 consecutive days. Ames, micronucleus, and chromosomal aberration tests were established to analyze the possible genotoxicity of $25-OCH_3-PPD$. Results: There was no $25-OCH_3-PPD$einduced systemic toxicity in beagle dogs at any doses. The level of $25-OCH_3-PPD$ at which no adverse effects were observed was found to be 240 mg/kg/day. The result of Ames test showed that there was no significant increase in the number of revertant colonies of $25-OCH_3-PPD$ administrated groups compared to the vehicle control group. There were also no significant differences between $25-OCH_3-PPD$ administrated groups at all dose levels and negative group in the micronucleus test and chromosomal aberration assay. Conclusion: The highest dose level of $25-OCH_3-PPD$ at which no adverse effects were observed was found to be 240 mg/kg per day, and it is not a genotoxic agent either in somatic cells or germs cells. $25-OCH_3-PPD$ is an extremely safe candidate compound for antitumor treatment.

Failure of Ciprofloxacin Therapy in the Treatment of Community-Acquired Acute Pyelonephritis caused by In-Vitro Susceptible Escherichia coli Strain Producing CTX-Type Extended-Spectrum β-Lactamase

  • Seok, Hyeri;Cha, Min Kyeong;Kang, Cheol-In;Cho, Sun Young;Kim, So Hyun;Ha, Young Eun;Chung, Doo Ryeon;Peck, Kyong Ran;Song, Jae-Hoon
    • Infection and chemotherapy
    • /
    • 제50권4호
    • /
    • pp.357-361
    • /
    • 2018
  • While carbapenems are the drug of choice to treat extended-spectrum-${\beta}$-lactamase (ESBL)-producing strains, some alternative carbapenem-sparing regimens are suggested for antibiotic stewardship. We experienced a case of ciprofloxacin treatment failure for acute pyelonephritis caused by an apparently susceptible Escherichia coli. A 71-year-old woman presented the emergency department with fever for 7 days and bilateral flank pain for 2 days. The laboratory results and abdominopelvic computed tomography finding were compatible with acute pyelonephritis. During 3-day ciprofloxacin therapy, the patient remained febrile with persistent bacteremia. After the change in antibiotics to ertapenem, the patient's clinical course started to improve. ESBL-producing E. coli isolates were identified in all three consecutive blood samples. Pulsed-field gel electrophoresis (PFGE) patterns, serotypes, and sequence types showed the three isolates were derived from the identical strain. The isolates produced CTX-M-14 type ESBL belonging to the ST69 clonal group. Despite in vitro susceptibility, the failure was attributed to a gyrA point mutation encoding Ser83Leu within quinolone resistance-determining regions. This case suggests that ciprofloxacin should be used cautiously in the treatment of serious infections caused by ciprofloxacin-susceptible, ESBL-producing E. coli, even in acute pyelonephritis because in-vitro susceptibility tests could fail to detect certain genetic mutations.